Areas of development
Areas of development
Pharmena translates scientific knowledge about the biological properties of the 1-methylnicotinamide (1-MNA) molecule into innovative products and technologies across several application areas.
The Company’s development activities are organized around three complementary areas reflecting different stages of innovation and market application.
Longevity
Longevity represents an important area of development focused on solutions supporting healthy aging and long-term vitality.
Within this area, Pharmena develops and commercializes science-based products built on the biological properties of the 1-MNA molecule. These solutions are designed to support physiological processes associated with metabolic balance, vascular function and overall vitality.
The longevity area is primarily represented by the Endotelio platform, which focuses on the development and commercialization of nutraceutical products and future innovations supporting healthy aging.
The longevity area is primarily represented by the Endotelio platform, which focuses on the development and commercialization of nutraceutical products and future innovations supporting healthy aging.
Longevity
Longevity represents an important area of development focused on solutions supporting healthy aging and long-term vitality.
Within this area, Pharmena develops and commercializes science-based products built on the biological properties of the 1-MNA molecule. These solutions are designed to support physiological processes associated with metabolic balance, vascular function and overall vitality.
The longevity area is primarily represented by the Endotelio platform, which focuses on the development and commercialization of nutraceutical products and future innovations supporting healthy aging.
The longevity area is primarily represented by the Endotelio platform, which focuses on the development and commercialization of nutraceutical products and future innovations supporting healthy aging.
Topical solutions
Topical Solutions represent Pharmena’s research and development activities focused on products intended for local application in selected medical and specialized areas.
This area includes the development of innovative formulations designed to address specific clinical needs through topical administration.
Current development programs include projects targeting hard-to-heal wounds and selected inflammatory skin conditions, as well as other specialized therapeutic areas.
These activities are carried out within the Synerixa platform, which integrates Pharmena’s research and development projects in the field of topical product technologies.
Current development programs include projects targeting hard-to-heal wounds and selected inflammatory skin conditions, as well as other specialized therapeutic areas.
These activities are carried out within the Synerixa platform, which integrates Pharmena’s research and development projects in the field of topical product technologies.
Topical solutions
Topical Solutions represent Pharmena’s research and development activities focused on products intended for local application in selected medical and specialized areas.
This area includes the development of innovative formulations designed to address specific clinical needs through topical administration.
Current development programs include projects targeting hard-to-heal wounds and selected inflammatory skin conditions, as well as other specialized therapeutic areas.
These activities are carried out within the Synerixa platform, which integrates Pharmena’s research and development projects in the field of topical product technologies.
Current development programs include projects targeting hard-to-heal wounds and selected inflammatory skin conditions, as well as other specialized therapeutic areas.
These activities are carried out within the Synerixa platform, which integrates Pharmena’s research and development projects in the field of topical product technologies.
Bioscience
Bioscience represents Pharmena’s long-term scientific activities focused on expanding knowledge related to the biology, health potential and therapeutic applications of the 1-MNA molecule.
Research conducted within this area aims to better understand the biological mechanisms of 1-MNA and identify potential therapeutic indications that could form the basis for future pharmaceutical innovations.
These activities are conducted within the MNAxis platform, which brings together Pharmena’s scientific research related to drug discovery and development.
These activities are conducted within the MNAxis platform, which brings together Pharmena’s scientific research related to drug discovery and development.
Bioscience
Bioscience represents Pharmena’s long-term scientific activities focused on expanding knowledge related to the biology, health potential and therapeutic applications of the 1-MNA molecule.
Research conducted within this area aims to better understand the biological mechanisms of 1-MNA and identify potential therapeutic indications that could form the basis for future pharmaceutical innovations.
These activities are conducted within the MNAxis platform, which brings together Pharmena’s scientific research related to drug discovery and development.
These activities are conducted within the MNAxis platform, which brings together Pharmena’s scientific research related to drug discovery and development.
Advancing Science.
Creating Value.
contact
PHARMENA S.A.
ul. Gdanska 47/49
90-729 Łodz, Poland
phone: +48 42 280 77 07
office@pharmena.eu
links
Advancing Science.
Creating Value.
contact
PHARMENA S.A.
ul. Gdanska 47/49
90-729 Łodz, Poland
phone: +48 42 280 77 07
office@pharmena.eu